Home | News & Insight | Pursuing quantum in pharma with purpose: An interview with Boehringer Ingelheim’s CTO

Pursuing quantum in pharma with purpose: An interview with Boehringer Ingelheim’s CTO

19th Dec 2022 | 12:00am

Clemens Utschig-Utschig discusses how his company is exploring quantum computing for its potential to propel next-generation drug discovery.